Creative Medical Technology Holdings, Inc. CELZ
We take great care to ensure that the data presented and summarized in this overview for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CELZ
Top Purchases
Top Sells
About CELZ
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Insider Transactions at CELZ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
200
+1.61%
|
$800
$4.36 P/Share
|
|
Jun 27
2023
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
800
+2.22%
|
$3,200
$4.44 P/Share
|
|
Nov 22
2022
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+4.12%
|
$0
$0.39 P/Share
|
|
Nov 21
2022
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
15,000
+7.0%
|
$0
$0.4 P/Share
|
|
Sep 27
2022
|
Michael H. Finger |
BUY
Open market or private purchase
|
Direct |
2,000
+9.76%
|
$0
$0.5 P/Share
|
|
Sep 27
2022
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+18.68%
|
$0
$0.5 P/Share
|
|
Sep 22
2022
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
12,000
+15.17%
|
$0
$0.54 P/Share
|
|
Sep 21
2022
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+13.45%
|
$0
$0.62 P/Share
|
|
Jun 14
2022
|
Michael H. Finger |
BUY
Open market or private purchase
|
Direct |
10,000
+37.73%
|
$0
$0.7 P/Share
|
|
Jun 06
2022
|
Timothy Warbington President & CEO |
BUY
Open market or private purchase
|
Direct |
25,000
+43.53%
|
$0
$0.92 P/Share
|
|
May 20
2022
|
Michael H. Finger |
BUY
Open market or private purchase
|
Direct |
6,500
+49.99%
|
$6,500
$1.5 P/Share
|
|
Jul 22
2021
|
Thomas Ichim |
SELL
Open market or private sale
|
Direct |
1,450,000
-24.25%
|
$0
$0.03 P/Share
|
|
Jul 21
2021
|
Thomas Ichim |
SELL
Open market or private sale
|
Direct |
1,500,000
-20.05%
|
$0
$0.03 P/Share
|
|
Jul 20
2021
|
Thomas Ichim |
SELL
Open market or private sale
|
Direct |
1,400,000
-15.77%
|
$0
$0.03 P/Share
|
|
Jun 28
2021
|
Thomas Ichim |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120,448
-11.2%
|
$0
$0.04 P/Share
|
|
Jun 28
2021
|
Thomas Ichim |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000,000
+50.0%
|
-
|
|
Jan 08
2021
|
Creative Medical Health Inc. |
BUY
Other acquisition or disposition
|
Direct |
44,642,857
+28.23%
|
-
|
|
Jan 08
2021
|
Timothy Warbington President & CEO |
BUY
Other acquisition or disposition
|
Indirect |
44,642,857
+28.23%
|
-
|
|
Sep 30
2020
|
Timothy Warbington President & CEO |
BUY
Other acquisition or disposition
|
Indirect |
42,328,042
+38.08%
|
-
|
|
Sep 30
2020
|
Creative Medical Health Inc. |
BUY
Other acquisition or disposition
|
Direct |
42,328,042
+38.08%
|
-
|